Clinical Trials Browser

Carcinoma, Renal Cell, Craniopharyngioma, Ependymoma, Glioma, Carcinoma, Hepatocellular, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Choroid Plexus Neoplasms, Sarcoma, Clear Cell, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT05278208 2025-10-20

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Phase 1/2 Recruiting

65 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

40 enrolled

CNS

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT06439420 2025-10-01

CBT-I in PBT

Phase 2 Completed

70 enrolled

CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

NCT04638478 2025-09-29

PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI

Recruiting

67 enrolled

CNS

Meningioma

NCT06831461 2025-09-16

PRIDE

Phase NA Recruiting

156 enrolled

CNSEndocrine

Brain Neoplasms, Meningioma, Pituitary Neoplasms

NCT03220646 2025-07-09

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2 Active not recruiting

64 enrolled

CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Meningioma, Oligodendroglioma

NCT06632860 2025-07-09

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

Phase EARLY_PHASE1 Recruiting

40 enrolled

CNS

Meningioma

NCT07056023 2025-07-09

EURJMT

Recruiting

100 enrolled

CNS

Meningioma, Spinal Cord Neoplasms

NCT04087902 2025-07-03

Long-Term Longitudinal QoL in Patients Undergoing EEA

Recruiting

400 enrolled

CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

NCT01892397 2025-07-02

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

Phase NA Active not recruiting

6 enrolled

CNS

Brain Neoplasms, Meningioma

NCT07044076 2025-06-29

MenQOL

Recruiting

50 enrolled

CNS

Meningioma

NCT06036706 2025-06-24

CANCER-COG

Phase NA Recruiting

108 enrolled

CNS

Meningioma, Radiation Injuries

NCT03583528 2025-06-13

DOTATOC PET/CT for Imaging NET Patients

Active not recruiting

800 enrolled

CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

50 enrolled

CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT05416567 2025-06-05

e-men

Phase NA Recruiting

30 enrolled

CNS

Brain Neoplasms, Meningioma

Clinical Trials

GM-HES

Abemaciclib in Newly Diagnosed Meningioma Patients

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

MOLI

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

PIVIM

SIMPLIF-AI

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

HiPPI

MOMENTUM-1

CSF-IMR

NEURO-SUTURE

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

MIND

BIOLIMEN-1

Evaluation of the CONVIVO System

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

MenQOL 2

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

A Study of ONC201 for Refractory Meningioma

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

INTUITT-NF2

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas

DOMINO-START

HOBSCOTCH-CA

Molecular-Guided Therapy for Childhood Cancer

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

EViDENCE-BT

CBT-I in PBT

PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI

PRIDE

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

EURJMT

Long-Term Longitudinal QoL in Patients Undergoing EEA

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

MenQOL

CANCER-COG

DOTATOC PET/CT for Imaging NET Patients

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

e-men